Vericel Corp. (VCEL)
42.36
-0.32
(-0.76%)
USD |
NASDAQ |
Aug 24, 16:00
42.36
0.00 (0.00%)
After-Hours: 19:56
Vericel Total Assets (Quarterly) : 502.87M for June 30, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Assets (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 502.87M |
| March 31, 2026 | 485.63M |
| December 31, 2025 | 487.97M |
| September 30, 2025 | 453.27M |
| June 30, 2025 | 435.61M |
| March 31, 2025 | 424.59M |
| December 31, 2024 | 432.72M |
| September 30, 2024 | 390.40M |
| June 30, 2024 | 376.84M |
| March 31, 2024 | 356.66M |
| December 31, 2023 | 353.66M |
| September 30, 2023 | 318.12M |
| June 30, 2023 | 310.71M |
| March 31, 2023 | 265.10M |
| December 31, 2022 | 273.00M |
| September 30, 2022 | 248.02M |
| June 30, 2022 | 244.82M |
| March 31, 2022 | 240.29M |
| December 31, 2021 | 243.70M |
| September 30, 2021 | 224.14M |
| June 30, 2021 | 221.94M |
| March 31, 2021 | 211.46M |
| December 31, 2020 | 205.61M |
| September 30, 2020 | 157.50M |
| June 30, 2020 | 146.69M |
| Date | Value |
|---|---|
| March 31, 2020 | 150.26M |
| December 31, 2019 | 153.24M |
| September 30, 2019 | 137.53M |
| June 30, 2019 | 125.83M |
| March 31, 2019 | 141.23M |
| December 31, 2018 | 118.69M |
| September 30, 2018 | 124.46M |
| June 30, 2018 | 122.19M |
| March 31, 2018 | 52.41M |
| December 31, 2017 | 54.58M |
| September 30, 2017 | 40.28M |
| June 30, 2017 | 36.53M |
| March 31, 2017 | 40.59M |
| December 31, 2016 | 48.60M |
| September 30, 2016 | 28.02M |
| June 30, 2016 | 29.43M |
| March 31, 2016 | 33.06M |
| December 31, 2015 | 34.31M |
| September 30, 2015 | 35.82M |
| June 30, 2015 | 41.22M |
| March 31, 2015 | 44.49M |
| December 31, 2014 | 47.58M |
| September 30, 2014 | 50.38M |
| June 30, 2014 | 19.84M |
| March 31, 2014 | 9.878M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| Krystal Biotech, Inc. | 1.501B |
| AbbVie, Inc. | 135.12B |
| Marker Therapeutics, Inc. | 14.59M |
| TG Therapeutics, Inc. | 1.640B |
| ADMA Biologics, Inc. | 684.21M |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 132.82M |
| Shareholders Equity (Quarterly) | 370.04M |
| Debt to Equity Ratio | 0.2556 |
| Current Ratio | 5.039 |
| Net Debt Paydown Yield | 0.06% |